Harry Gill

Board Member
Mr. Harry Gill is Senior Vice President, Operations of Editas Medicine. He joined Editas Medicine in September 2019 as interim Head of Operations and was named Senior Vice President, Operations in January 2020.

Mr. Gill brings more than 30 years of life sciences experience to this role. Throughout his career, he has held leadership roles in quality, plant operations, technical services, and operational excellence.

He served as Senior Vice President of Quality and Continuous Improvement at Patheon pharmaceuticals (now ThermoFisher Scientific). Earlier in his career, he held various positions at Wyeth (now Pfizer Pharmaceuticals) and Baxter Healthcare Corporation. In addition, he has eight years of international experience, holding manufacturing operations positions in Asia and Puerto Rico.

Mr. Gill received a B.S. in Biology from Milligan College and a M.S. in Microbiology from East Tennessee State University.